Targeted delivery of vaccine to dendritic cells by chitosan nanoparticles conjugated with a targeting peptide ligand selected by phage display technique.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Macromolecular Bioscience

• Publication date

  2015-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/mabi.201400352PMID 25393207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functionalization of polyanhydride microparticles with di-mannose influences uptake by and intracellular fate within dendritic cells.

  2013cited by this paper
• Chitosan Nanoparticles as Therapeutic Protein Nanocarriers: the Effect of pH on Particle Formation and Encapsulation Efficiency

  2013cited by this paper
• Targeting of macrophage galactose‐type C‐type lectin (MGL) induces DC signaling and activation

  2012cited by this paper
• A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles.

  2012cited by this paper
• Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.

  2012cited by this paper
• 5-fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics

  2012cited by this paper
• Engineering Nano‐ and Microparticles to Tune Immunity

  2012cited by this paper
• Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN.

  2012cited by this paper
• The impact of nanoparticle ligand density on dendritic-cell targeted vaccines.

  2011cited by this paper
• Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells.

  2011cited by this paper
• Targeting Antigen to Mouse Dendritic Cells via Clec9A Induces Potent CD4 T Cell Responses Biased toward a Follicular Helper Phenotype

  2011cited by this paper
• Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.

  2011cited by this paper
• The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.

  2011cited by this paper
• Unmet needs in modern vaccinology: adjuvants to improve the immune response.

  2010cited by this paper
• Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique.

  2010cited by this paper
• Synthesis of glycocluster-tumor antigenic peptide conjugates for dendritic cell targeting.

  2007cited by this paper
• Differential Antigen Processing by Dendritic Cell Subsets in Vivo

  2007cited by this paper
• Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin.

  2007cited by this paper
• Enhanced and prolonged cross‐presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

  2006cited by this paper
• Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.

  2006cited by this paper
• Targeting dendritic cells with biomaterials: developing the next generation of vaccines.

  2006cited by this paper
• Antigen delivery via two molecules on the CD8– dendritic cell subset induces humoral immunity in the absence of conventional “danger”

  2005cited by this paper
• In vitro study of the immune stimulating activity of an atrophic [correction of athrophic] rhinitis vaccine associated to chitosan microspheres.

  2004cited by this paper
• Uptake of FITC-Chitosan Nanoparticles by A549 Cells

  2002cited by this paper
• Phagocytosis of microbes: complexity in action.

  2002cited by this paper
• Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance

  2002cited by this paper
• A peptide carrier for the delivery of biologically active proteins into mammalian cells

  2001cited by this paper
• Investigation on a novel core-coated microspheres protein delivery system.

  2001cited by this paper
• Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors.

  1996cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper

• Emerging trends in viral infection inhibition using a chitosan-based drug delivery system

  2025cites this paper
• Pathogen biosensors for food safety and public healthcare based on specific biological probes biopanned by phage display: A critical review.

  2025cites this paper
• Synthesis and Characterization of Peptide-Chitosan Engineered Nanoparticles as an Ideal Platform for Food Preservation, Cosmetics, and Pharmaceutical Applications

  2025cites this paper
• Exploration of chitosan and its modified derivatives as vaccine adjuvant: A Review

  2024cites this paper
• Application of locally responsive design of biomaterials based on microenvironmental changes in myocardial infarction

  2023cites this paper
• Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design

  2023cites this paper
• Refining the DC-targeting vaccination for preventing emerging infectious diseases

  2022cites this paper
• Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines

  2022cites this paper
• Targeting dendritic cells with TLR-2 ligand–coated nanoparticles loaded with Mycobacterium tuberculosis epitope induce antituberculosis immunity

  2022cites this paper
• Bridging nanoplatform and vaccine delivery, a landscape of strategy to enhance nasal immunity.

  2022cites this paper
• Mucosal vaccination through chitosan-based delivery systems

  2022cites this paper
• An overview of chitosan and its application in infectious diseases

  2021cites this paper
• Phage nanofibers in nanomedicine: Biopanning for early diagnosis, targeted therapy, and proteomics analysis.

  2020cites this paper
• pH-sensitive and specific ligand-conjugated chitosan nanogels for efficient drug delivery.

  2019cites this paper
• Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.

  2019cites this paper
• Biodegradable Polymeric Nanocarrier-Based Immunotherapy in Hepatitis Vaccination.

  2018cites this paper
• Needle-Free Immunization with Chitosan-Based Systems

  2018cites this paper
• Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases.

  2017cites this paper
• Design of nanoparticle structures for cancer immunotherapy

  2017cites this paper
• Novel nanoparticles based on chitosan-dicarboxylate conjugates via tandem ionotropic/covalent crosslinking with tripolyphosphate and subsequent evaluation as drug delivery vehicles.

  2017cites this paper
• Development of RNA aptamer that inhibits methyltransferase activity of dengue virus

  2017cites this paper
• PLGA nanoparticles modified with a TNFα mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation.

  2016cites this paper
• Purification of DNA vaccine to prevent or treat cervical cancer

  2016cites this paper
• Polymer-Based DNA Delivery Systems for Cancer Immunotherapy

  2016cites this paper